BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ali K, Hamed MA, Hassan H, Esmail A, Sheneef A. Identification of Fungal Pathogens in Otomycosis and Their Drug Sensitivity: Our Experience. Int Arch Otorhinolaryngol 2018;22:400-3. [PMID: 30357045 DOI: 10.1055/s-0038-1626702] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Aboutalebian S, Mahmoudi S, Mirhendi H, Okhovat A, Abtahi H, Chabavizadeh J. Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agents. J Med Microbiol 2019;68:918-23. [PMID: 31063125 DOI: 10.1099/jmm.0.000985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Aboutalebian S, Mahmoudi S, Okhovat A, Khodavaisy S, Mirhendi H. Otomycosis Due to the Rare Fungi Talaromyces purpurogenus, Naganishia albida and Filobasidium magnum. Mycopathologia 2020;185:569-75. [PMID: 32232764 DOI: 10.1007/s11046-020-00439-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang S, Jin M, Hu S, Zhang Y, Zhou G. Administration of 1% topical voriconazole drops was effective and safe in the treatment of refractory otomycosis without tympanic membrane perforation. Ann Otol Rhinol Laryngol 2021;130:273-9. [PMID: 32772544 DOI: 10.1177/0003489420946783] [Reference Citation Analysis]
4 Osman M, Bidon B, Abboud C, Zakaria A, Hamze B, Achcar ME, Mallat H, Dannaoui E, Dabboussi F, Papon N, Bouchara JP, Hamze M. Species distribution and antifungal susceptibility of Aspergillus clinical isolates in Lebanon. Future Microbiol 2021;16:13-26. [PMID: 33438473 DOI: 10.2217/fmb-2020-0141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chen Q, Chu H, Tao Y, Peng L, Zhou L, Liu L, Wu X. A Comparison of Triamcinolone Acetonide Econazole Cream and Nystatin Suspension in Treatment of Otomycosis. Laryngoscope 2021;131:E1640-6. [PMID: 33141477 DOI: 10.1002/lary.29190] [Reference Citation Analysis]
6 [DOI: 10.1101/541185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gülüstan F, Abakay MA, Demir E. Efficacy of topical isoconazole nitrate in the treatment of otomycosis. Am J Otolaryngol 2021;42:102961. [PMID: 33621764 DOI: 10.1016/j.amjoto.2021.102961] [Reference Citation Analysis]
8 Kiakojuri K, Mahdavi Omran S, Roodgari S, Taghizadeh Armaki M, Hedayati MT, Shokohi T, Haghani I, Javidnia J, Kermani F, Badali H, Abastabar M. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis. Mycopathologia 2021;186:245-57. [PMID: 33718990 DOI: 10.1007/s11046-021-00537-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Sangaré I, Amona FM, Ouedraogo RW, Zida A, Ouedraogo MS. Otomycosis in Africa: Epidemiology, diagnosis and treatment. J Mycol Med 2021;31:101115. [PMID: 33516991 DOI: 10.1016/j.mycmed.2021.101115] [Reference Citation Analysis]
10 Gits-Muselli M, Hamane S, Verillaud B, Cherpin E, Denis B, Bondeelle L, Touratier S, Alanio A, Garcia-Hermoso D, Bretagne S. Different repartition of the cryptic species of black aspergilli according to the anatomical sites in human infections, in a French University hospital. Med Mycol 2021:myab027. [PMID: 34022772 DOI: 10.1093/mmy/myab027] [Reference Citation Analysis]